(주)네이처셀 · KOSDAQ: 007390 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩19.4B | ₩32.3B | ₩20.7B |
| Operating income | −₩10.3B | ₩598M | −₩3.6B |
| Net income | −₩11.7B | ₩1.2B | −₩2.8B |
| Total assets | ₩68.4B | ₩72.0B | ₩74.7B |
| Total liabilities | ₩7.0B | ₩7.4B | ₩11.7B |
| Total equity | ₩61.4B | ₩64.6B | ₩63.0B |
| Share capital | ₩32.1B | ₩32.2B | ₩32.2B |
Consolidated statements · FY2025 operating margin -17.6% · liabilities to equity 19% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 55 (current) | 삼일회계법인 | Unqualified |
| Term 54 (prior) | 삼일회계법인 | Unqualified |
| Term 53 (two years prior) | 삼일회계법인 | Unqualified |
| Date | Largest shareholder (Korean) | Stake | Cause (Korean) |
|---|---|---|---|
| 2023년 02월 08일 | (주)바이오스타그룹 외 9 | — | 변경 전 최대주주의 지분 매각 |
| Date | Filing | Original |
|---|---|---|
| 2026-08-26 | Decision to acquire shares of another company | DART |
| 2026-08-26 | Paid-in capital increase (rights offering) decision | DART |
| 2026-08-14 | Half-year report (2026.06) | DART |
| 2026-08-07 | Securities issuance results (voluntary) | DART |
| 2026-08-03 | Stock option grant | DART |
| 2026-07-31 | Other management matter (voluntary) | DART |
| 2026-07-22 | Material event report — Convertible bond issuance decision | DART |
| 2026-07-09 | Other management matter (voluntary) | DART |
| 2026-06-05 | Investor relations event | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-03-31 | Annual general meeting results | DART |
| 2026-03-27 | Officer / major shareholder ownership report | DART |
| 2026-03-23 | Annual report (2025.12) | DART |
| 2026-03-23 | Audit report submitted | DART |
| 2026-03-20 | Officer / major shareholder ownership report | DART |
| 2026-03-20 | Change of CEO | DART |
| 2026-03-16 | Clarification of rumor or media report | DART |
| 2026-03-04 | Investor relations event | DART |
| 2026-02-19 | Notice of shareholders meeting | DART |
| 2026-02-19 | Proxy solicitation reference document | DART |
Showing the 20 most recent of 35 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.